Most people in medtech know of Earl Bakken’s contributions to pacemakers and cardiac rhythm devices, but without Otis Boykin, pacemakers wouldn’t have the pacing technology they do today. Boykin, an African-American inventor and engineer, had a special interest in resistors. His mother died from heart failure when he was 1 year old. Thirty-one years later, […]
Boston Scientific posts mixed bag Q4 results
Boston Scientific (NYSE:BSX) posted fourth-quarter results that beat the earnings consensus on Wall Street, but missed on revenue. The Marlborough, Mass.-based company reported profits of $4 billion, or $2.83 per share, on sales of $2.9 billion for the three months ended Dec. 31, 2019, for a bottom-line gain of 935.2% sales growth of 13.43% compared with […]
Boston Sci issues urgent field safety notice for Maestro cardiac ablation system
Boston Scientific (NYSE:BSX) issued an urgent field safety notice to warn of a firmware installation update for its Maestro 4000 cardiac ablation system after issues with radiofrequency delivery. In June 2018, Boston Scientific notified customers of the potential for the unintended continuation of radiofrequency energy emitted from the device after releasing its foot switch. After releasing […]
These medical device companies provide the most research payments
The worlds largest medical device companies are spending tens of millions of dollars a year on research payments to doctors and teaching hospitals — but the payments only make up a tiny fraction of their budgets. That was a big takeaway from an analysis of Medical Design & Outsourcing‘s annual Big 100 and the most […]
Collagen Matrix hires ex-Boston Scientific GM as CEO
Collagen Matrix announced that it appointed former Boston Scientific (NYSE:BSX) executive Shawn McCarthy as its new CEO and as a member of its board of directors, effective Jan. 27. A nearly 30-year veteran of the medical device industry, McCarthy most recently served as GM of structural heart valves at Boston Scientific. There, he was responsible for […]
Study: High- and low-dose drug-coated balloons equally effective in PAD
A Boston Scientific (NYSE:BSX) device coated with less of the controversial drug paclitaxel than one made by Medtronic (NYSE:MDT) is just as safe and effective for patients with peripheral artery disease (PAD), according to a study published this week. The prospective, randomized controlled trial compared the lower-dose (2 μg/mm2 of paclitaxel) Boston Scientific Ranger drug-coated ballon (DCB) […]
Boston Sci wins CE Mark for disposable duodenoscope Exalt Model D
Boston Scientific (NYSE:BSX) this week received CE Mark approval for its Exalt disposable duodenoscope. The Exalt Model D Single-Use Duodenoscope is designed for use in endoscopic retrograde cholangiopancreatography procedures. It is the first single-use duodenoscope on the U.S. market and was granted Breakthrough Device Designation. The FDA cleared the device late last year. “Following on from […]
Boston Scientific to appeal order to finish failed $275M merger
Boston Scientific (NYSE:BSX) will appeal a court order requiring it to complete its $275 million purchase of Channel Medsystems. On Dec. 10. 2019, a Delaware chancery court judge ordered Boston Scientific to finish the merger. In a lawsuit filed in September 2018, Channel claimed that Boston Scientific spiked the deal over a former Channel employee’s scheme to […]
Boston Scientific wins a round in patent spat with Micro-Tech
A federal judge in Delaware ruled yesterday that Boston Scientific may proceed in its patent dispute with Micro-Tech over hemostatic endoscopy clips. Boston Scientific filed the lawsuit against Micro-Tech USA and its Chinese manufacturer, Micro-Tech Nanjing, alleging that they infringed three of its patents for endoscopic hemostatic clips. Henry Schein (Melville, N.Y.) is named as […]
Boston Scientific shares drop on Q4 sales news
Shares in Boston Scientific (NYSE:BSX) dropped 8% this morning on news of disappointing fourth-quarter sales. The company’s preliminary earnings report showed sales for the quarter ended Dec. 31, 2019 coming in at $2.9 billion, below the $2.91 billion that analysts were expecting. The unaudited sales figure represents organic growth of 7.3%, missing the company’s own […]
The 10 greatest medtech advances of the 2010s
From disposable endoscopes to TAVR to robotic surgery, there’s a whole host of medtech advances widely available now that weren’t around much 10 years ago. “In terms of technological advances, I would put this past decade as one of the most important for medical technology. From connected devices and robotics, to advances in material sciences […]
- 1
- 2
- 3
- …
- 143
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube